Kala Pharmaceuticals Inc. buy HC Wainwright
Start price
02.04.24
/
50%
€7.37
Target price
02.04.25
€19.50
Performance (%)
-20.77%
Price
01.08.24
€5.82
Summary
This prediction is currently active. The price of Kala Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.77%. This prediction currently runs until 02.04.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kala Pharmaceuticals Inc. | -11.626% | -11.626% |
iShares Core DAX® | -1.377% | -1.442% |
iShares Nasdaq 100 | 0.827% | -5.117% |
iShares Nikkei 225® | 0.198% | -0.851% |
iShares S&P 500 | 1.364% | -0.887% |
Comments by HC_Wainwright for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Stopped prediction by HC_Wainwright for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.08
17.05.24
17.05.24
€16.55
17.05.25
17.05.25
-3.95%
01.08.24
01.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.00
17.11.23
17.11.23
€20.23
17.11.24
17.11.24
16.90%
01.08.24
01.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.63
11.08.23
11.08.23
€21.91
11.08.24
11.08.24
-53.80%
01.08.24
01.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.19
27.03.23
27.03.23
€18.53
27.03.24
27.03.24
-44.50%
28.03.24
28.03.24